Skip to main content
Caplight Logo









Z Prime Therapeutics

Z Prime Therapeutics

Private
Mountain View, CaliforniaHealthcare & Life Scienceshttps://zprimetx.com/

Company Overview

Z Prime Therapeutics is a drug discovery company that develops precision oncology therapeutics using synthetic lethality to target genetically defined tumors.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

precision oncologysmall molecule therapeuticssynthetic lethalitydrug discoverytechbiocomputational biologyoncology pipelinegenetically defined cancertargeted therapybiotech startupundruggable targetsai-augmented drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Z Prime Therapeutics Comparables

Compare Z Prime Therapeutics with similar companies based on industry and business-model similarity.

Z Prime Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Delphia Therapeutics
84%
Eisbach Bio GmbH
82%
Evariste
81%

Z Prime Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Z Prime Therapeutics Investors

Notable investors and investment history

Z Prime Therapeutics investors
InvestorRounds
Boutique Venture PartnersPre Seed

Z Prime Therapeutics Filings

Explore SEC and related filing metadata, where available.

Z Prime Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Z Prime Therapeutics's valuation, stock price, and market status.

Is Z Prime Therapeutics a public or private company?

Z Prime Therapeutics is a private company.

What is the current stock price of Z Prime Therapeutics?

Z Prime Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Z Prime Therapeutics worth (valuation)?

Valuation information for Z Prime Therapeutics is not publicly available.

Can I buy Z Prime Therapeutics stock?

Z Prime Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Z Prime Therapeutics's last funding round?

Funding round information for Z Prime Therapeutics is not publicly available.

Who are the main investors in Z Prime Therapeutics?

Key investors in Z Prime Therapeutics include Boutique Venture Partners.

Will Z Prime Therapeutics IPO soon?

No public IPO plans have been announced for Z Prime Therapeutics.

How can I track Z Prime Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Z Prime Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMountain View, California
Year Founded2025
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?